“We’re giving you something so we get something in return”

While there are concerns of increasing vulnerability and undue risk taking with compensation, there is a need to explore the impact of different types of compensation on vulnerable populations’ voluntary consent and how it shapes research-related interactions. By exploring the impact of compensation on study participants, the researchers hope to inform the ethical framework around compensation policy. This study draws on five focus groups conducted with 25 people living with HIV who use drugs and are clients at the Dr. Peter Centre, a community based HIV care facility in Vancouver, Canada. It explores the ethics surrounding perceptions of research compensation practices by research participants.

Citation: Collins, Alexandra B., et al. ““We’re giving you something so we get something in return”: Perspectives on research participation and compensation among people living with HIV who use drugs.” International Journal of Drug Policy 39 (2017): 92-98.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below